Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;47(4):42.
doi: 10.3892/ijmm.2021.4875. Epub 2021 Feb 12.

Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review)

Affiliations
Review

Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review)

Qi Li et al. Int J Mol Med. 2021 Apr.

Abstract

Myocardial ischemia/reperfusion injury (MIRI) may cause myocardial stunning, reperfusion arrhythmia, no‑reflow phenomenon and lethal reperfusion injury, which has a significant effect on the prognosis of patients undergoing thrombolytic agent therapy and percutaneous coronary intervention. Increasing evidence suggests that apoptosis, innate inflammation, oxidative stress, calcium overload and autophagy are involved in the pathogenesis of MIRI. Recent advancements in RNA sequencing technologies and genome‑wide analyses led to the finding of small non‑coding RNAs (ncRNAs). ncRNAs modulate cellular processes such as signal transduction, transcription, chromatin remodeling and post‑transcriptional modification. The effects of ncRNAs on cellular biology is more considerable than initially expected, and thus ncRNAs have gained increasing attention and focus in modern medical research. There are several types of ncRNAs, such as microRNAs (miRNAs), long non‑coding RNAs (lncRNAs) and circular RNAs (circRNAs), which have been shown to regulate gene expression at the transcription, post‑transcription and epigenetic levels. Dysregulation of ncRNAs, including miRNAs, lncRNAs and circRNAs, may participate in the molecular mechanisms of MIRI. The present review summarizes the characteristics and biological roles of miRNAs, lncRNAs and circRNAs, with particular emphasis on their role in MIRI, which show the novel complexity of ischemic hearts and may offer valuable insights into the pathogenesis of MIRI.

Keywords: myocardial ischemia/reperfusion injury; microRNA; long non‑coding RNA; circular RNA; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
The biogenesis of miRNA, lncRNA and ciRNA. (a) miRNA genes are transcribed as pri-miRNA by RNA Pol II after which they are mediated by DRCG8 and RNAse III endonuclease Drosha, and pre-miRNA translocates from the nucleus to the cytoplasm mediated by exportin 5. Then, the RNase III endonuclease Dicer interacting with TRBP cleaves the pre-miRNA and mature miRNAs are incorporated into the RISC. (b) LncRNA genes are transcribed mostly by Pol II, and its biogenesis process is similar to miRNA. (c) circRNAs are generated by back-splicing events on maturing pre-mRNA that join together an exon at the upstream 3′ splice site to an exon at the downstream 5′ splice site resulting in a circular product, including exon, intron and exon-intron circRNA. circRNAs that are generated from exons only are mostly found in the cytoplasm, which suggests a role in post-transcriptional gene regulation. pri-miRNA, primary miRNA; Pol II, polymerase II; DRCG8, DiGeorge syndrome criticial region 8; pre-miRNA, precursor miRNA; TRBP, TAR RNA-binding protein; RISC, RNA-induced silencing complex.

Similar articles

Cited by

References

    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. Heart Disease and Stroke Statistics-2019 Update: A report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
    1. Ibanez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65:1454–1471. doi: 10.1016/j.jacc.2015.02.032. - DOI - PubMed
    1. Wang EW, Han YY, Jia XS. PAFR-deficiency alleviates myocardial ischemia/reperfusion injury in mice via suppressing inflammation, oxidative stress and apoptosis. Biochem Biophys Res Commun. 2018;495:2475–2481. doi: 10.1016/j.bbrc.2017.12.132. - DOI - PubMed
    1. Zheng J, Li J, Kou B, Yi Q, Shi T. MicroRNA-30e protects the heart against ischemia and reperfusion injury through autophagy and the Notch1/Hes1/Akt signaling pathway. Int J Mol Med. 2018;41:3221–3230. - PMC - PubMed
    1. Xu T, Ding W, Ao X, Chu X, Wan Q, Wang Y, Xiao D, Yu W, Li M, Yu F, Wang J. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening. Redox Biol. 2019;20:414–426. doi: 10.1016/j.redox.2018.10.023. - DOI - PMC - PubMed

MeSH terms